Clinical Trial Update: Clinical Study of FB1001 in Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical study of FB1001 sponsored by Shanghai General Hospital/Shanghai Jiao Tong University School of Medicine is listed, evaluating its use for opt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angle-closure Glaucoma
• Non-arteritic Anterior Ischemic Optic Neuropathy
• Optic Neuropathy

Drugs mentioned

• FB1001 (FB1001)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Optic Neuropathy, NAION - Non-Arteritic Ischemic Optic Neuropathy | Phase 1 | Status: NOT_YET_RECRUITING